PRevention Using EPA Against coloREctal Cancer

Condition:   Colorectal Adenoma Intervention:   Drug: AMR101 (VASCEPA, icosapent ethyl) Sponsors:   Harvard Medical School;   Harvard School of Public Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials